Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ib/II Study of Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer

NCT07665684 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT07665684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07665684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ib/II Study of Samuraciclib in Combination With Gemcitabine/Nab-Paclitaxel in Patients With Metastatic Basal-Like Pancreatic Cancer
Lead sponsor
University Health Network, Toronto
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
July 31, 2026
Completion date
May 31, 2030
Enrollment
67 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenosquamous carcinoma of the pancreas, mucinous adenocarcinoma, pancreas cancer, metastatic, pancreas ductal adenocarcinoma, pancreatic adenocarcinoma metastatic